This website provides educational information about medicines and active ingredients. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Pharmacists

Tavneos 10 mg Hard Capsules: Uses, Safety & Info

Quick summary: Tavneos 10 mg hard capsules contain avacopan and are used in adults with severe active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). It is taken by mouth and is used as...

Educational content Use this article as a starting point for understanding the topic.
Check with a professional Ask a doctor or pharmacist before changing any medicine.
Safety first Side effects, interactions and risks depend on each person.
Medical disclaimer

This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.

Quick summary: Tavneos 10 mg hard capsules contain avacopan and are used in adults with severe active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). It is taken by mouth and is used as part of a wider treatment plan.

Key points: take it exactly as prescribed, with food, and keep up with monitoring, especially liver function checks.

Medical disclaimer: This article is for general information only and does not replace the official patient leaflet, product information, or advice from a doctor or pharmacist. Do not use it to diagnose a condition or to make treatment changes.

What Tavneos 10 mg hard capsules are used for

Tavneos 10 mg hard capsules are a prescription medicine used in adults with severe, active granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

The active ingredient is avacopan. It acts as a selective complement 5a receptor inhibitor and is used to help reduce inflammation linked to these autoimmune conditions.

In practice, Tavneos is typically used alongside other therapies such as rituximab or cyclophosphamide, depending on the treatment plan chosen by the healthcare team.

How Tavneos works

Avacopan targets the complement 5a receptor, which is part of the immune response involved in inflammation. By blocking this receptor, Tavneos helps reduce the inflammatory process that can damage blood vessels in GPA and MPA.

This mechanism is different from broad immune suppression, which is why it is often discussed separately from traditional immunosuppressant medicines.

How Tavneos is taken

Tavneos should be taken exactly as prescribed by a healthcare professional.

  • It is taken by mouth.
  • It is usually taken twice daily.
  • It should be taken with food.
  • The capsules should be swallowed whole with water.

Do not crush, chew, or break the capsules unless a healthcare professional has specifically advised otherwise.

Dosage information

The current content states that the recommended total daily dose is 30 mg per day, given as two doses. Because dosing can depend on the full treatment plan, the official product information and the prescriber’s instructions should always be checked.

If anything about the dose is unclear, a pharmacist or doctor should confirm the exact schedule.

Possible side effects

Like all medicines, Tavneos can cause side effects. The current content lists the following as more common examples:

  • Nausea
  • Fatigue
  • Headache
  • Skin rash

More serious concerns can include liver function impairment. Symptoms such as yellowing of the skin or eyes, dark urine, or severe abdominal pain should be reported promptly to a healthcare professional.

If any new or worsening symptoms appear during treatment, medical advice should be sought without delay.

Who should not use Tavneos

The current content identifies the following situations as important contraindications or reasons for avoiding use:

  • Severe hepatic impairment
  • Allergy to avacopan
  • Active serious infections

Tavneos is also not recommended for children under 12 years of age according to the current content.

Pregnant or breastfeeding people should discuss the medicine with a healthcare professional, since the benefits and risks need individual assessment.

Monitoring while taking Tavneos

Regular monitoring is important during treatment. The current content highlights liver function monitoring as a key safety measure.

Healthcare professionals may also check for signs of infection and may monitor blood pressure, depending on the overall treatment plan and the person’s condition.

Patients should report symptoms such as fatigue, jaundice, abdominal discomfort, or any unusual change in health status.

At a glance

Topic Summary
Active ingredient Avacopan
Use Adults with severe active GPA or MPA
How it is taken By mouth, usually twice daily, with food
Main monitoring point Liver function

Frequently asked questions

▸ What is the mechanism of action of Tavneos?

Tavneos works by selectively inhibiting the complement 5a receptor, which helps reduce inflammation linked to GPA and MPA.

▸ What is the active ingredient in Tavneos?

The active ingredient is avacopan. Each hard capsule contains 10 mg of avacopan.

▸ Is Tavneos used on its own?

The current content says Tavneos is typically used with other therapies such as rituximab or cyclophosphamide, depending on the treatment plan.

▸ Is Tavneos an immunosuppressant?

The current content says Tavneos is not classified as an immunosuppressant. It works by modulating the immune response through the complement system.

▸ Is Tavneos FDA approved?

The current content states that Tavneos has received FDA approval for use in severe active GPA and MPA.

▸ What should be checked before taking Tavneos?

A healthcare professional should review liver health, infection status, allergies, current medicines, and the full treatment plan before use.

Safety reminder

Before using Tavneos, patients should confirm the exact instructions in the official product information and speak with a doctor or pharmacist about any symptoms, other medicines, liver concerns, or infection risks. Seek urgent medical advice for signs of liver problems or serious illness.

Editorial note Active Ingredients Online Editorial Team This article is prepared as educational medicine information for general readers. It is written to support understanding of active ingredients, medicine uses, possible side effects, precautions and safety-related questions.
Published: December 6, 2024 Updated: August 17, 2026 Educational content

Medical disclaimer

This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.

Sources and verification

The following sources or official references are listed to support verification of the medicine information discussed in this article.

Final note

Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.

Ask a Doctor Online medical questions